The occurrence of benign brain tumours in transgender individuals during cross-sex hormone treatment

Hypothetically, transgender individuals receiving hormonal therapy may have an increased risk of (hormone-sensitive) brain tumours. Nota et al. report that cross-sex hormone treatment is associated with a higher risk of meningiomas and prolactinomas in transwomen, and somatotrophinomas in transmen....

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Brain (London, England : 1878) England : 1878), 2018-07, Vol.141 (7), p.2047-2054
Hauptverfasser:	Nota, Nienke M, Wiepjes, Chantal M, de Blok, Christel J M, Gooren, Louis J G, Peerdeman, Saskia M, Kreukels, Baudewijntje P C, den Heijer, Martin
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Brain Neoplasms - etiology Cyproterone Acetate - adverse effects Female Gender Identity Gonadal Steroid Hormones - adverse effects Gonadal Steroid Hormones - therapeutic use Humans Incidence Male Netherlands Retrospective Studies Transgender Persons - psychology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!